Literature DB >> 6812496

In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

D L Winslow, G A Pankey.   

Abstract

The in vitro activities of trimethoprim and sulfamethoxyazole against clinical isolates of Listeria monocytogenes were examined separately and in combination with a microtiter broth dilution system. Sulfamethoxazole demonstrated variable activity and was generally bacteriostatic. Trimethoprim alone was bactericidal against 96% of isolates at less than 0.5 microgram/ml. The bactericidal action of trimethoprim against L. monocytogenes was generally potentiated by sulfamethoxyazole even when isolates were relatively resistant to sulfamethoxyazole alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812496      PMCID: PMC183673          DOI: 10.1128/AAC.22.1.51

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Letter: Trimethoprim-sulfamethoxazole and bacterial meningitis.

Authors:  Z Farid; N I Girgis; W Yassin
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

Review 2.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Central nervous system infections in patients with cancer.

Authors:  N L Chernik; D Armstrong; J B Posner
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

4.  Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.

Authors:  M C Bach; M Finland; O Gold; C Wilcox
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes.

Authors:  R C Gordon; F F Barrett; D J Clark
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

6.  Listeria monocytogenes meningitis during immunosuppression.

Authors:  G Nirmul; S Glabman; M Haimov; E Leiter; L Burrows
Journal:  N Engl J Med       Date:  1971-12-02       Impact factor: 91.245

7.  Ampicillin treatment of listeriosis.

Authors:  R C Gordon; F F Barrett; M D Yow
Journal:  J Pediatr       Date:  1970-12       Impact factor: 4.406

8.  Listeroisis in immunosuppressed patients. A cluster of eight cases.

Authors:  N M Gantz; R L Myerowitz; A A Medeiros; G F Carrera; R E Wilson; T F O'Brien
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

9.  Antibiotic synergism against Listeria monocytogenes.

Authors:  R C Moellering; G Medoff; I Leech; C Wennersten; L J Kunz
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

10.  Requirement of thymus (T) lymphocytes for resistance to listeriosis.

Authors:  F C Lane; E R Unanue
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Listeriosis in human pregnancy: a systematic review.

Authors:  Ronald F Lamont; Jack Sobel; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Sun Kwon Kim; Niels Uldbjerg; Roberto Romero
Journal:  J Perinat Med       Date:  2011-04-25       Impact factor: 1.901

Review 2.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 3.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

Authors:  F R Sattler; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

Review 6.  Antibiotic susceptibilities of Listeria: in vitro studies.

Authors:  E P Espaze; A E Reynaud
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Listeria monocytogenes meningitis in a young woman with systemic lupus erythematosus.

Authors:  Ming-Chia Lee; Yao-Kuang Wu; Chun-Hsiung Chen; Ta-Wei Wu; Chih-Hsin Lee
Journal:  Rheumatol Int       Date:  2010-07-29       Impact factor: 2.631

Review 8.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

9.  Susceptibilities of Listeria species isolated from food to nine antimicrobial agents.

Authors:  C M Franco Abuín; E J Quinto Fernández; C Fente Sampayo; J L Rodríguez Otero; L Domínguez Rodríguez; A Cepeda Sáez
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997).

Authors:  Amar Safdar; Donald Armstrong
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.